Global Retina Health Market 2023-2029
The retina is a layer of tissue at the back of the eye that contains light-sensitive cells called photoreceptors. The retina plays a critical role in vision, as it converts light into electrical signals that are sent to the brain. Maintaining retina health is important for preserving vision and preventing vision loss. The global retina health market is likely to register a CAGR of over 7.25% with an incremental growth of USD 8.0 billion during the forecast period 2023-2029.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global retina health market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the treatment, and disease indication, and region. The global market for retina health can be segmented by treatment: drugs, therapy, surgery. Globally, the drugs segment made up the largest share of the retina health market. Retina health market is further segmented by disease indication: age-related macular degeneration, diabetic retinopathy, inherited retinal diseases, retinoblastoma, others. The age-related macular degeneration segment captured the largest share of the market in 2022. On the basis of region, the retina health market also can be divided into: North America, Europe, Asia-Pacific, Rest of the World (RoW). North America held the largest revenue share in 2022.
Market Segmentation
By treatment: drugs, therapy, surgery
By disease indication: age-related macular degeneration, diabetic retinopathy, inherited retinal diseases, retinoblastoma, others
By region: North America, Europe, Asia-Pacific, Rest of the World (RoW)
The report also provides a detailed analysis of several leading retina health market vendors that include Novartis AG, Allergan plc, Santen Pharmaceuticals Inc., Regenxbio Inc., MeiraGTx Limited, Spark Therapeutics, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global retina health market.
To classify and forecast the global retina health market based on treatment, disease indication, region.
To identify drivers and challenges for the global retina health market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global retina health market.
To identify and analyze the profile of leading players operating in the global retina health market.
Why Choose This Report
Gain a reliable outlook of the global retina health market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global retina health market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the treatment, and disease indication, and region. The global market for retina health can be segmented by treatment: drugs, therapy, surgery. Globally, the drugs segment made up the largest share of the retina health market. Retina health market is further segmented by disease indication: age-related macular degeneration, diabetic retinopathy, inherited retinal diseases, retinoblastoma, others. The age-related macular degeneration segment captured the largest share of the market in 2022. On the basis of region, the retina health market also can be divided into: North America, Europe, Asia-Pacific, Rest of the World (RoW). North America held the largest revenue share in 2022.
Market Segmentation
By treatment: drugs, therapy, surgery
By disease indication: age-related macular degeneration, diabetic retinopathy, inherited retinal diseases, retinoblastoma, others
By region: North America, Europe, Asia-Pacific, Rest of the World (RoW)
The report also provides a detailed analysis of several leading retina health market vendors that include Novartis AG, Allergan plc, Santen Pharmaceuticals Inc., Regenxbio Inc., MeiraGTx Limited, Spark Therapeutics, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global retina health market.
To classify and forecast the global retina health market based on treatment, disease indication, region.
To identify drivers and challenges for the global retina health market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global retina health market.
To identify and analyze the profile of leading players operating in the global retina health market.
Why Choose This Report
Gain a reliable outlook of the global retina health market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY TREATMENT
Drugs
Therapy
Surgery
PART 6. MARKET BREAKDOWN BY DISEASE INDICATION
Age-related macular degeneration
Diabetic retinopathy
Inherited retinal diseases
Retinoblastoma
Others
PART 7. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
Rest of the World (RoW)
PART 8. KEY COMPANIES
Novartis AG
Allergan plc
Santen Pharmaceuticals Inc.
Regenxbio Inc.
MeiraGTx Limited
Spark Therapeutics, Inc.
DISCLAIMER
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY TREATMENT
Drugs
Therapy
Surgery
PART 6. MARKET BREAKDOWN BY DISEASE INDICATION
Age-related macular degeneration
Diabetic retinopathy
Inherited retinal diseases
Retinoblastoma
Others
PART 7. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
Rest of the World (RoW)
PART 8. KEY COMPANIES
Novartis AG
Allergan plc
Santen Pharmaceuticals Inc.
Regenxbio Inc.
MeiraGTx Limited
Spark Therapeutics, Inc.
DISCLAIMER
